A carregar...

Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer

In recent years, significant advances have been made in the management of metastatic colorectal cancer. Traditionally, an improvement in overall survival has been considered the “gold standard”—the most convincing measure of efficacy. However, overall survival requires larger patient numbers and lon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gill, S., Berry, S., Biagi, J., Butts, C., Buyse, M., Chen, E., Jonker, D., Mărginean, C., Samson, B., Stewart, J., Thirlwell, M., Wong, R., Maroun, J.A.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3176908/
https://ncbi.nlm.nih.gov/pubmed/21969810
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!